- Home
- KALA vs KFFB Comparison
KALA vs KFFB Comparison
Compare KALA & KFFB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KALA
- KFFB
- Stock Information
- Founded
- KALA 2009
- KFFB 2005
- Country
- KALA United States
- KFFB United States
- Employees
- KALA N/A
- KFFB N/A
- Industry
- KALA Biotechnology: Pharmaceutical Preparations
- KFFB Savings Institutions
- Sector
- KALA Health Care
- KFFB Finance
- Exchange
- KALA Nasdaq
- KFFB Nasdaq
- Market Cap
- KALA 32.0M
- KFFB 26.4M
- IPO Year
- KALA 2017
- KFFB 2005
- Fundamental
- Price
- KALA $6.77
- KFFB $2.65
- Analyst Decision
- KALA Strong Buy
- KFFB
- Analyst Count
- KALA 2
- KFFB 0
- Target Price
- KALA $16.50
- KFFB N/A
- AVG Volume (30 Days)
- KALA 36.4K
- KFFB 11.7K
- Earning Date
- KALA 11-12-2024
- KFFB 11-12-2024
- Dividend Yield
- KALA N/A
- KFFB 15.09%
- EPS Growth
- KALA N/A
- KFFB N/A
- EPS
- KALA N/A
- KFFB N/A
- Revenue
- KALA N/A
- KFFB $7,475,000.00
- Revenue This Year
- KALA N/A
- KFFB N/A
- Revenue Next Year
- KALA N/A
- KFFB N/A
- P/E Ratio
- KALA N/A
- KFFB N/A
- Revenue Growth
- KALA N/A
- KFFB N/A
- 52 Week Low
- KALA $4.21
- KFFB $2.50
- 52 Week High
- KALA $10.97
- KFFB $5.18
- Technical
- Relative Strength Index (RSI)
- KALA 53.32
- KFFB 39.04
- Support Level
- KALA $6.65
- KFFB $2.50
- Resistance Level
- KALA $7.85
- KFFB $2.70
- Average True Range (ATR)
- KALA 0.36
- KFFB 0.21
- MACD
- KALA -0.02
- KFFB -0.03
- Stochastic Oscillator
- KALA 7.43
- KFFB 13.51
About KALA KALA BIO Inc.
Kala Bio Inc is a biopharmaceutical company. The company is a clinical-stage biopharmaceutical company dedicated to researching, developing, and commercializing therapies for rare and severe eye diseases. KALA'smain product candidate, KPI-012, is a human MSC-S, which contains numerous human-derived biofactors, such as growth factors, protease inhibitors, matrix proteins, and neurotrophic factors that can potentially correct the impaired corneal healing that is an underlying etiology of multiple severe ocular diseases. Its MSC-S platform is for retinal degenerative diseases, such as Retinitis Pigmentosa and Stargardt Disease.
About KFFB Kentucky First Federal Bancorp
Kentucky First Federal Bancorp is a holding company. The company through its subsidiaries is engaged mainly in the business of accepting deposits from the general public and using such funds to originate loans secured by first mortgages on owner-occupied, residential real estate and other loans secured by real estate. Its primary products and services include Residential mortgage loans, Multi-family loans, Construction loans and types of deposits, etc. The company mainly operates in Perry, Franklin, Boyle and Garrard and surrounding counties in Kentucky, US.